Design Therapeutics, Inc. (DSGN) Balance Sheet
As of 2026-06-30 (10-Q), Design Therapeutics, Inc. (DSGN) reported total assets of $215.1M, total liabilities of $13.3M and shareholders' equity of $201.9M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $12.9M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
DSGNDesign Therapeutics, Inc.Follow DSGN — free
—
Price chart with a free account
- Market cap
- 640.8M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 11 Nov, in 18 days
| Line | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|
| Cash and equivalents | 298.6 | 26.5 | 21.2 | 22.6 | 16.9 | 12.9 | |
| Short-term investments | 85.5 | 303.9 | 260.6 | 222.9 | 203.0 | 194.5 | |
| Current assets | 385.4 | 335.1 | 284.6 | 248.0 | 223.8 | 212.0 | |
| Total assets | 390.6 | 341.1 | 289.6 | 252.1 | 226.2 | 215.1 | |
| Current liabilities | 5.3 | 10.8 | 9.6 | 8.5 | 13.1 | 11.2 | |
| Total liabilities | 8.4 | 13.8 | 12.0 | 10.0 | 13.7 | 13.3 | |
| Shareholders' equity | 382.1 | 327.3 | 277.7 | 242.1 | 212.5 | 201.9 |
USD millions · SEC XBRL
Design Therapeutics, Inc. — questions
- How much cash does Design Therapeutics, Inc. have?
- $12.9M in cash and cash equivalents as of 2026-06-30.
- What are Design Therapeutics, Inc.'s total assets?
- $215.1M as of 2026-06-30.
- What is Design Therapeutics, Inc.'s shareholders' equity?
- $201.9M as of 2026-06-30.
Every figure on this page comes from Design Therapeutics, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.